On this segment of "American Health Journal," Dr. Eric Kortz of Swedish Medical Center in Denver, Colorado, discusses NanoKnife technology for treating cancer. NanoKnife is used in the ablation of hard-to-reach tumors, including those that are not good candidates for surgery because of their location near other important areas of the body, where surgery would be too risky. Dr. Kortz had had good success killing tumors of the pancreas, liver and bile ducts with NanoKnife. The procedure is safe and FDA approved. To learn more about NanoKnife treatment for cancer.
we go now to our reporter laura windsor who has more on a new cancer treatment
there's now a new technology probably shouldn't have to respond now tonight
and uses electrical pulses to kill hard to reach cancers
we went to swedish medical center and spoke to dr eric courts about this new
technology and asked him what what is in our night and how does that differ from
other forms of tumor ablation internet is currently being used
to kilter hers that otherwise cannot be respected because they are around
important structures
it's also being used to treat those tumors that can be resected but are very
close to very important structures
so we can preserve those important structures but read around then to make
sure
that's a complete tumors being able to be treated
after the present time than patient population and particularly looking at
her patients who have take res cancer bile duct cancer liver cancer or even
colon cancers in certain locations
particularly though for pancreatic cancer patients and four bile duct
cancer patients we've never had a technique that we can locally destroyer
tumor the reason most of the local destructive techniques require heat
and heat will disrupt these clients and end up with a beacon ductal structures
so we can't have that
so really for the first time we have a local publishing technique for these
cancers that her un recyclable
we've never before had technology
that records tells us how effective the now and i can start telling tumor cells
mennonite is very safe and very effective
it has a very high percentage of initial kill
and there can be some areas that need to be retrieved that its initial killers a
very high percentage
extremely safe as well
they're not does not replace the current concepts of
removing the tumor completely
when it surgically possible that's going to be our number one recommendation
it does not replace chemotherapy or radiation
this is a new way to effectively kill or killing a margin extension manifestation
for tumors that otherwise may not be resected or need additional treatment
around specific important structures
that records discusses how important are now in my fears for a patient who can't
be treated with surgery
sonication to can't be surgically resected
doesn't respond well to chemotherapy doesn't respond well to radiation
protocol
we now have for the first time home for completion technique
to really get a handle on destruction of this tumor
that opens up the opportunity
for better control subsequently with chemotherapy or the potential for even
turning allusion that was an respectable into one that has risen
this is the first time we've been able to have technology that opens up a brand
new pharmacotherapy considerations for patients we just didn't have a response
form
and for these patients in pancreatic tumors and biliary tumors that
percentage of patients is relatively high he can effect anywhere up to forty
to fifty percent of pancreatic patients cannot be considered for research
this is not experimental this is undergoing a lot of
basic science research is a
designated from the decades it's been being utilized and worked in cell
biology
sasa being used as a trickling technique males of thousands of patients
it does carry a hat approval from the f_d_a_
and entrance companies certainly recovering this is a procedure that's
very important
and and i think cancer patients any lesion therapy treatment option
this new technology allows physicians to treat lesions that are not well treated
by other methods
for the american health general i'm laura windsor
more information on stocks reports or help someone swedish medical center
called one eight seven seven thousand one doesn't help one cares dot com
Prev: 納米刀在腹腔鏡下治療肝癌案例
Next: Dr.Yoo談美國癌癥治療中心對納米刀的應用